Details for Patent: 7,858,594
✉ Email this page to a colleague
Summary for Patent: 7,858,594
Title: | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
Abstract: | Physical forms of beta-L-2'-deoxythymidine are disclosed that can be characterized by physical appearance, purity levels, Infra-Red and Raman spectroscopy, X-ray powder diffraction patterns, thermal properties, and methods of manufacture. These forms of beta-L-2'-deoxythymidine can be used in the manufacture of other forms of beta-L-2'-deoxythymidine, or in pharmaceutical compositions. Particularly preferred uses are in the treatment of hepatitis B. |
Inventor(s): | Jonaitis; David (West Lafayette, IN), Storer; Richard (Kent, GB) |
Assignee: | Novartis Pharma AG (Basel, CH) |
Application Number: | 12/505,839 |
Patent Claim Types: see list of patent claims | Compound; Formulation; Composition; Dosage form; Use; |
Drugs Protected by US Patent 7,858,594
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,858,594
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003265396 | ⤷ Try a Trial | |||
China | 100376593 | ⤷ Try a Trial | |||
China | 1714098 | ⤷ Try a Trial | |||
European Patent Office | 1534727 | ⤷ Try a Trial | |||
European Patent Office | 2607370 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |